Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana. more
Time Frame | ELAN | Sector | S&P500 |
---|---|---|---|
1-Week Return | -6.12% | -3.35% | -2.97% |
1-Month Return | -11.19% | -3.49% | -0.66% |
3-Month Return | -21.57% | -12.6% | 2.71% |
6-Month Return | -35.05% | -6.91% | 7.21% |
1-Year Return | -17.28% | 1.19% | 23.04% |
3-Year Return | -58.09% | -0.21% | 28.43% |
5-Year Return | -59.17% | 33.09% | 82.88% |
10-Year Return | -67.17% | 93.55% | 184.63% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 3.07B | 3.27B | 4.76B | 4.42B | 4.42B | [{"date":"2019-12-31","value":64.45,"profit":true},{"date":"2020-12-31","value":68.69,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":92.72,"profit":true},{"date":"2023-12-31","value":92.7,"profit":true}] |
Cost of Revenue | 1.47B | 1.67B | 2.13B | 1.91B | 2.48B | [{"date":"2019-12-31","value":59.31,"profit":true},{"date":"2020-12-31","value":67.23,"profit":true},{"date":"2021-12-31","value":86.08,"profit":true},{"date":"2022-12-31","value":77.17,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 1.60B | 1.61B | 2.63B | 2.50B | 1.94B | [{"date":"2019-12-31","value":60.84,"profit":true},{"date":"2020-12-31","value":61.07,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":95.21,"profit":true},{"date":"2023-12-31","value":73.66,"profit":true}] |
Gross Margin | 52.12% | 49.09% | 55.22% | 56.70% | 43.88% | [{"date":"2019-12-31","value":91.93,"profit":true},{"date":"2020-12-31","value":86.57,"profit":true},{"date":"2021-12-31","value":97.38,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":77.38,"profit":true}] |
Operating Expenses | 1.23B | 1.68B | 2.33B | 2.12B | 1.61B | [{"date":"2019-12-31","value":52.84,"profit":true},{"date":"2020-12-31","value":72.28,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":90.81,"profit":true},{"date":"2023-12-31","value":69.21,"profit":true}] |
Operating Income | 342.60M | 101.50M | 297.00M | 358.00M | 326.00M | [{"date":"2019-12-31","value":95.7,"profit":true},{"date":"2020-12-31","value":28.35,"profit":true},{"date":"2021-12-31","value":82.96,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":91.06,"profit":true}] |
Total Non-Operating Income/Expense | (343.30M) | (739.80M) | (1.11B) | (697.00M) | (1.79B) | [{"date":"2019-12-31","value":-34330000000,"profit":false},{"date":"2020-12-31","value":-73980000000,"profit":false},{"date":"2021-12-31","value":-111100000000,"profit":false},{"date":"2022-12-31","value":-69700000000,"profit":false},{"date":"2023-12-31","value":-179300000000,"profit":false}] |
Pre-Tax Income | 78.20M | (672.00M) | (567.00M) | (66.00M) | (1.20B) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-859.34,"profit":false},{"date":"2021-12-31","value":-725.06,"profit":false},{"date":"2022-12-31","value":-84.4,"profit":false},{"date":"2023-12-31","value":-1528.13,"profit":false}] |
Income Taxes | 10.30M | (111.90M) | (95.00M) | 8.00M | 36.00M | [{"date":"2019-12-31","value":28.61,"profit":true},{"date":"2020-12-31","value":-310.83,"profit":false},{"date":"2021-12-31","value":-263.89,"profit":false},{"date":"2022-12-31","value":22.22,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income After Taxes | 67.90M | (560.10M) | (472.00M) | (74.00M) | (1.23B) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-824.89,"profit":false},{"date":"2021-12-31","value":-695.14,"profit":false},{"date":"2022-12-31","value":-108.98,"profit":false},{"date":"2023-12-31","value":-1812.96,"profit":false}] |
Income From Continuous Operations | 67.90M | (560.10M) | (472.00M) | (74.00M) | (1.14B) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-824.89,"profit":false},{"date":"2021-12-31","value":-695.14,"profit":false},{"date":"2022-12-31","value":-108.98,"profit":false},{"date":"2023-12-31","value":-1684.83,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 67.90M | (560.10M) | (472.00M) | (74.00M) | (1.23B) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-824.89,"profit":false},{"date":"2021-12-31","value":-695.14,"profit":false},{"date":"2022-12-31","value":-108.98,"profit":false},{"date":"2023-12-31","value":-1812.96,"profit":false}] |
EPS (Diluted) | 1.06 | 0.47 | 1.05 | 1.11 | 0.89 | [{"date":"2019-12-31","value":95.5,"profit":true},{"date":"2020-12-31","value":42.34,"profit":true},{"date":"2021-12-31","value":94.59,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":80.18,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
ELAN | |
---|---|
Cash Ratio | 0.37 |
Current Ratio | 2.55 |
Quick Ratio | 1.31 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
ELAN | |
---|---|
ROA (LTM) | 1.18% |
ROE (LTM) | 3.24% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
ELAN | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.51 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.49 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
ELAN | |
---|---|
Trailing PE | 28.61 |
Forward PE | 12.35 |
P/S (TTM) | 1.30 |
P/B | 0.89 |
Price/FCF | 48 |
EV/R | 2.17 |
EV/Ebitda | 7.23 |
PEG | 1.84 |
Elanco Animal Health (ELAN) share price today is $11.82
Yes, Indians can buy shares of Elanco Animal Health (ELAN) on Vested. To buy Elanco Animal Health from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ELAN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Elanco Animal Health (ELAN) via the Vested app. You can start investing in Elanco Animal Health (ELAN) with a minimum investment of $1.
You can invest in shares of Elanco Animal Health (ELAN) via Vested in three simple steps:
The 52-week high price of Elanco Animal Health (ELAN) is $18.8. The 52-week low price of Elanco Animal Health (ELAN) is $11.4.
The price-to-earnings (P/E) ratio of Elanco Animal Health (ELAN) is 28.6098
The price-to-book (P/B) ratio of Elanco Animal Health (ELAN) is 0.89
The dividend yield of Elanco Animal Health (ELAN) is 0.00%
The market capitalization of Elanco Animal Health (ELAN) is $5.80B
The stock symbol (or ticker) of Elanco Animal Health is ELAN